These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 1890361)

  • 1. A clinical, immunological, and histological study of neuritic leprosy patients.
    Kaur G; Girdhar BK; Girdhar A; Malaviya GN; Mukherjee A; Sengupta U; Desikan KV
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):385-91. PubMed ID: 1890361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic efficacy of cutaneous nerve biopsy in primary neuritic leprosy.
    Jacob M; Mathai R
    Int J Lepr Other Mycobact Dis; 1988 Mar; 56(1):56-60. PubMed ID: 3373086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinico-pathological study of primary neuritic leprosy.
    Pannikar VK; Arunthathi S; Chacko CJ; Fritschi EP
    Lepr India; 1983 Apr; 55(2):212-21. PubMed ID: 6632781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histological changes in the nerve, skin and nasal mucosa of patients with primary neuritic leprosy.
    Suneetha S; Arunthathi S; Kurian N; Chacko CJ
    Acta Leprol; 2000-2001; 12(1):11-8. PubMed ID: 11526636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viability of Mycobacterium leprae in skin and peripheral nerves and persistence of nerve destruction in multibacillary patients after 2 years of multidrug therapy.
    Job CK; Jayakumar J; Aschhoff M; Mathan MM
    Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):44-50. PubMed ID: 8627112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological profiles of leprosy patients and healthy family contacts toward M. leprae antigens.
    Ilangumaran S; Ramanathan S; Shankernarayan N; Ramu G; Muthukkarauppan V
    Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):6-14. PubMed ID: 8627115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and histopathological observations on pure neuritic leprosy.
    Uplekar MW; Antia NH
    Indian J Lepr; 1986; 58(4):513-21. PubMed ID: 3572092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neurological manifestations of leprosy].
    Grimaud J; Vallat JM
    Rev Neurol (Paris); 2003 Nov; 159(11):979-95. PubMed ID: 14710019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy of far-advanced lepromatous leprosy patients with low-dose convit vaccine along with multidrug therapy (Calcutta trial).
    Majumder V; Mukerjee A; Hajra SK; Saha B; Saha K
    Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):26-36. PubMed ID: 8627110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local nerve damage in leprosy does not lead to an impaired cellular immune response or decreased wound healing in the skin.
    Siddiqui MR; Moreira AL; Negesse Y; Taye GA; Hanekom WA; Haslett PA; Britton S; Kaplan G
    J Infect Dis; 2002 Jul; 186(2):260-5. PubMed ID: 12134264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classification of nerves is modified by the delayed recognition of Mycobacterium leprae.
    Ridley DS; Ridley MJ
    Int J Lepr Other Mycobact Dis; 1986 Dec; 54(4):596-606. PubMed ID: 3546549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sub-clinical infection with Mycobacterium leprae in household contacts of leprosy.
    Bhatia VN; Dhandayuthapani S; Ananthan D; Rajendran M; Vasanth B; Jayasingh K; Kumar CH
    Indian J Lepr; 1990; 62(3):296-304. PubMed ID: 2262713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of clinical, histological and immunological features across the leprosy spectrum.
    Narayan NP; Ramu G; Desikan KV; Vallishayee RS
    Indian J Lepr; 2001; 73(4):329-42. PubMed ID: 11898465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of gene probes and its correlation with clinical profile of leprosy in children.
    Dayal R; Agarwal PK; Kalra K; Bharadwaj VP; Katoch VM; Katoch K
    Indian Pediatr; 1994 Dec; 31(12):1521-7. PubMed ID: 7875812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the immune deficit in leprosy patients and the effect of recombinant IL-2 in vitro.
    Locniskar M; McEniry DW; Mudd DW; Rose P; Lucas DC; Larrick J; McAdam KP
    Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):249-60. PubMed ID: 3298472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathologic evidence to show that indeterminate leprosy may be a primary lesion of the disease.
    Job CK; Baskaran B; Jayakumar J; Aschhoff M
    Int J Lepr Other Mycobact Dis; 1997 Dec; 65(4):443-9. PubMed ID: 9465152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A quantitative study of the relationship between systemic and histological parameters of immunity in individual leprosy patients.
    Cree IA; Smith WC; Beck JS
    Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):347-52. PubMed ID: 2198317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuritic leprosy: further progression and significance.
    Mishra B; Mukherjee A; Girdhar A; Husain S; Malaviya GN; Girdhar BK
    Acta Leprol; 1995; 9(4):187-94. PubMed ID: 8711979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epidemiological immunological studies on leprosy in Okinawa. 6. Lepromin, lymphocyte transformation, FLA-ABS and leproagglutination tests in the in-and out-patients with leprosy and the relationships among these tests and personal or family history or clinical findings of the patients].
    Minagawa F; Yoshino Y; Abe M; Saito N; Ohsawa Y; Ozawa T; Saikawa K
    Nihon Rai Gakkai Zasshi; 1989; 58(2):92-111. PubMed ID: 2697714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactions in borderline leprosy.
    Ramu G; Desikan KV
    Indian J Lepr; 2002; 74(2):115-28. PubMed ID: 12708730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.